awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36210992-388C0A9E-44E8-492D-8E96-ABEF12ABE271
Q36210992-388C0A9E-44E8-492D-8E96-ABEF12ABE271
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36210992-388C0A9E-44E8-492D-8E96-ABEF12ABE271
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.
P2860
Q36210992-388C0A9E-44E8-492D-8E96-ABEF12ABE271
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36210992-388C0A9E-44E8-492D-8E96-ABEF12ABE271
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e905613913f8c8414e78fb4edaf1fd8cb7fb8fd7
P2860
HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma.